Enabling confident differential diagnostics in dementia
cNeuro is Combinostics’ cloud platform for quantitative assessment of brain images and for providing clinical decision support in neurological disorders.
Combinostics offers two modules in the cNeuro product family, cMRI and cDSI.
Quantify volumes of 133 brain regions, vascular burden, medial temporal lobe atrophy (MTA) score, global cortical atrophy (GCA) scale and Fazekas scale.
Compare measures to reference data.
Review results interactively in a web viewer using a standard web browser and obtain a report.
Compare neuropsychology, MRI, CSF and genetics measured from your patient to data of previously diagnosed cases.
Quantify the patient’s similarity relative to etiology (AD, FTLD, VaD and cognitive normal) and progression (stable and progressive MCI).
Visualize data in an intuitive way with our patented disease state fingerprint (DSI) technology.
Three journal papers relevant to cNeuro have been published in early 2019. Visual rating scales are commonly used in assessing MRI images of patients with cognitive disorders, especially in Europe. The paper in European Radiology shows that such rating scales can be...read more
Combinostics will be attending the ECR conference in Vienna 27 February – 3 March. We will showcase our cNeuro® cMRI application for quantitative analysis of MRI scans, and our cNeuro® cDSI application for clinical decision support in dementia. You will find us in the...read more
Combinostics selected for the MassChallenge HealthTech’s 2019 Cohort of Top Digital Health Companies
Combinostics today announced that the company has been selected for the MassChallenge HealthTech 2019 program in Boston. MassChallenge is a global network of zero-equity startup accelerators. Combinostics was selected for the Boston program by a pool of institutions,...read more